Skip to main content
ADVANCED SEARCH
Log in

Home

Be confident that your patient care is up to date

Springer Medicine provides trustworthy, tailored, cutting‑edge content for medical professionals 

Selecting critical updates; keeping you informed; saving you time

Join now

Why register?  Our editorial team filters the most critical updates into tailored newsletters that deliver bitesize news, webinars, and CME direct to your inbox.  » Learn more

Editor's Choice

Coarctation of the abdominal aorta hidden for 80 years

Congenital coarctation of the abdominal aorta is issue usually diagnosed early in life. In this unusual case, it was discovered in an asymptomatic 80 year old man during a routine medical. The issue had been masked by compensatory dilatation of the splanchnic artery. 

Cat claw causes fulminant endophthalmitis

Open globe injuries from a cat claw may result in hyperacute and acute endophthalmitis. Despite immediate interventions in these two cases, both patients developed retinal detachment and had poor final visual acuity.

Medical nutrition therapy in dermatological diseases

Acne, hidradenitis suppurativa, and psoriasis are all influenced by obesity and metabolic and dietary factors. Clinical management should ideally include a dermatologist, endocrinologist, and nutritionist.

Extrarenal Wilms tumor in the retroperitoneum

A 6-year-old with abdominal pain and swelling was diagnosed with an extrarenal Wilms tumor located in the retroperitoneal space. ERWT should be considered in the differential diagnosis of abdominal pain, particularly in young children.

Episode 19: GLP-1 medicines - past, present, and future

From diabetes to obesity and beyond

In 2005 the US FDA approved the first GLP-1 medicine for type 2 diabetes, marking the start of a remarkable journey that goes beyond the stimulation of insulin secretion.

Prof. Daniel Drucker gives us a fascinating insight into the early work on GLP-1 and discusses how these medicines are impacting the lives of people with diabetes and obesity. He covers what's known about how they work, treatment duration, side effects, and the role of bariatric surgery, plus what's in the pipeline in terms of drug development and the indications that GLP-1 medicines may be used to treat in the future.

Prof. Daniel Drucker
Listen now
Podcast

Most Viewed

The evolving treatment landscape of advanced prostate cancer

Advanced diffusion-weighted imaging biomarkers for non-invasive assessment of tumor microenvironment in rectal cancer: restricted spectrum imaging

Iron rod-induced perforating head injury

Migraine with and without aura: two distinct entities?

Prophylactic magnesium backed for cancer patients starting cisplatin

The nuances of SIBO breath testing

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Latest CME and eLearning

Video (Link opens in a new window)

How can your team use biomarkers to improve diagnosis and management of AD? Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

Webinar

In this interactive webinar, experts discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations. 

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Developed by: Springer Healthcare

Expert Interviews (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in early diagnosis of AD, disease staging, and guiding treatment decisions. But how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Register your interest

Latest News

Adrenalectomy ‘valid option’ for MACS due to unilateral adrenal incidentaloma

Efruxifermin fails to reduce fibrosis in MASH-related compensated cirrhosis

Fremanezumab shows dual benefit in reducing migraine and depression

No survival benefit of statins in HER2-positive breast cancer

Revascularization no additional benefit in intermediate-to-low risk carotid stenosis

Study highlights inter-facility variation in diabetic foot care

SPONSORED

Targeting COPD with type 2 inflammation: emerging biologic landscape

1.5 European CME credits (ECMEC®s)

Watch an insightful session tailored for pulmonologists and healthcare professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies.

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare
Watch now
Video

Medical Journals

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Latest Open Access Reviews

Hypoxic-ischemic spinal cord injury following resuscitated cardiac arrest: a case series and rapid literature review

  • Open Access
  • Review Article/Brief Review

Exploring the Efficacy and Safety of Argatroban as an Adjunct to Antiplatelet Therapy in Ischemic Stroke Patients: A Systematic Review and Meta-analysis

  • Open Access
  • Review

Acute ischemic stroke (AIS) is a major cause of disability and mortality worldwide. While antiplatelet therapy is standard for secondary prevention, many patients still experience early neurological deterioration (END). Argatroban, a direct …

Multimorbidity and fluid biomarkers of Alzheimer's disease: a systematic review

  • Open Access
  • Review

In the last decades, fluid biomarkers have gained increasing importance in dementia research, particularly in Alzheimer’s disease (AD) [ 1 ]. Measured in cerebrospinal fluid (CSF) and blood, these biomarkers offer a window into the brain by …

Pericytes in hematogenous metastasis: mechanistic insights and therapeutic approaches

  • Open Access
  • Review

Metastasis, the leading cause of cancer-related deaths, underscores the critical need to understand its regulatory mechanisms to improve prevention and treatment strategies for late-stage tumors. Hematogenous dissemination is a key route of …

Episode 18: The fight for children's eyesight

What can we do to reduce mounting myopia prevalence?

Global prevalence of myopia in children and adolescents is set to reach 40% by 2050, exceeding 740 million cases.

Reducing incidence and slowing progression is essential, as myopia is linked to sight-threatening complications like retinal detachment, myopic macular degeneration, and glaucoma. Dr. Annegret Dahlmann-Noor explores the reasons behind this increase and what we can do to halt the trend.

Dr. Annegret Dahlmann-Noor
Listen now
Podcast

About Springer Medicine

Better-informed doctors make better decisions. Which is why we’ve launched Springer Medicine, a pan-European, English-language, medical education platform. Our mission is to educate doctors on the latest clinical advances, so you can offer your patients the best possible care. 

Building on Springer Nature’s reputation as a guardian of scientific knowledge and thought-leadership, using our comprehensive wealth of clinical content and established relationships with international experts, Springer Medicine is committed to empowering you with the knowledge you need for your patients. 

» Learn more about our mission

Listen to the Medicine Matters Podcast

Medicine Matters is a pan-specialty podcast for doctors, that discusses the most exciting, controversial, and practice-changing topics across medical practice as a whole. In our episodes, we talk to leading clinical experts, to researchers and funding institutes, and to industry partners about the well-known and perhaps the lesser-known issues affecting doctors in their clinics. We examine everything from new drug approvals to social issues affecting medicine, challenging some of the status quo along the way.

You can also subscribe via:  Spotify | Apple Podcasts | Deezer

Browse episodes

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Register today
Image Credits